Autologous

Wilmington, Delaware, United States, July 04, 2023 (GLOBE NEWSWIRE) -- The global pericardial patches market is anticipated to grow at a 6.8% CAGR from 2023 to 2031. A market valuation of…

RICHMOND, Va., June 06, 2023 (GLOBE NEWSWIRE) -- CELLF BIO achieved a major milestone with the world's first human implantation of BioSphincter™, an autologous bioengineered sphincter…

SINGAPORE, May 30, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological…

<!-- Name:DistributionId Value:8842437 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Pune, Jan. 17, 2023 (GLOBE NEWSWIRE) -- According to Maximize Market Research, the Autologous Cell Therapy Market worth USD 26.1 Billion by 2029, growing at a 21.5% CAGR. The market is…

Elana Gotkine WEDNESDAY, Dec. 28, 2022 (HealthDay News) -- For patients with active secondary progressive multiple sclerosis (SPMS), autologous…

Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete response rate from 15 heavily pre-treated…

CAMBRIDGE, Mass., Dec. 10, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today…

Portland, OR, Dec. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Autologous Cell Therapy Market generated $4.3 billion in 2021, and…

Enrollment continues in clinical trial of MB-106 under Mustang’s IND; next data disclosure anticipated 4Q 2022 Ongoing clinical trial of MB-106 at Fred Hutch continues to demonstrate high…